福元医药：“联苯苄唑溶液”取得注册证

Group 1 - The core point of the article is that Fuyuan Pharmaceutical has received a drug registration certificate from the National Medical Products Administration for its product, Lianbenbengzhuo Solution, which allows for its production [2]. Group 2 - Fuyuan Pharmaceutical's subsidiary, Fuyuan Pharmaceutical Co., Ltd., is responsible for the production of Lianbenbengzhuo Solution [2]. - The approval of the drug registration certificate signifies a regulatory milestone for the company, potentially enhancing its product portfolio [2].